EDAP TMS (FOCL)
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic...
- Open
- 4.230
- High
- 4.240
- Low
- 4.075
- Prev. Close
- 4.240
- Volume
- 236.36K
- Turnover
- 985.47K
- Avg Price
- 4.169
- Bid/Ask Ratio
- --
- Amplitude
- 3.89%
- 52wk High
- 6.400
- Volume Ratio
- 3.97
- Turnover Ratio
- 0.65%
EDAP TMS Analyst Rating
View moreForecast & Rating
Aug 14, 2026Price forecast
$8.60108.23%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy0.00%
- Hold40.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 days ago, 03:16 PM
Edap TMS files initial beneficial ownership statement for Guy Levy
- Market Beat · Aug 20 at 12:41 AM
FocalTherics (FOCL) Projected to Announce Quarterly Earnings on Thursday
- Motley Fool · Aug 17 at 07:41 PM
Upwork (UPWK) Q2 2026 Earnings Call Transcript
- Market Beat · Aug 17 at 06:07 AM
Insider Buying: FocalTherics (NASDAQ:FOCL) General Counsel Purchases $23,750.00 in Stock
- PUBT · Aug 17 at 05:09 AM
Edap TMS CFO Kenneth S. Mobeck buys 5,000 common shares for $23,750
- Market Beat · Aug 14 at 09:14 AM
FocalTherics (NASDAQ:FOCL) Receives Average Rating of "Hold" from Brokerages
